97 related articles for article (PubMed ID: 27503387)
1. Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived Cardiomyocytes.
Millard DC; Strock CJ; Carlson CB; Aoyama N; Juhasz K; Goetze TA; Stoelzle-Feix S; Becker N; Fertig N; January CT; Anson BD; Ross JD
Toxicol Sci; 2016 Nov; 154(1):174-182. PubMed ID: 27503387
[TBL] [Abstract][Full Text] [Related]
2. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Bradycardiac Effects Caused by Co-Administration of Sofosbuvir and Amiodarone.
Yu Y; Liu F; He L; Ramakrishna S; Zheng M; Bu L; Xu Y
Assay Drug Dev Technol; 2018; 16(4):222-229. PubMed ID: 29847141
[TBL] [Abstract][Full Text] [Related]
3. Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells.
Lagrutta A; Zeng H; Imredy J; Balasubramanian B; Dech S; Lis E; Wang J; Zhai J; DeGeorge J; Sannajust F
Toxicol Appl Pharmacol; 2016 Oct; 308():66-76. PubMed ID: 27520758
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
5. Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry.
Lagrutta A; Regan CP; Zeng H; Imredy JP; Koeplinger K; Morissette P; Liu L; Wollenberg G; Brynczka C; Lebrón J; DeGeorge J; Sannajust F
Sci Rep; 2017 Mar; 7():44820. PubMed ID: 28327633
[TBL] [Abstract][Full Text] [Related]
6. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
[TBL] [Abstract][Full Text] [Related]
7. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Ca
Yao X; Gao S; Wang J; Li Z; Huang J; Wang Y; Wang Z; Chen J; Fan X; Wang W; Jin X; Pan X; Yu Y; Lagrutta A; Yan N
Cell; 2022 Dec; 185(25):4801-4810.e13. PubMed ID: 36417914
[TBL] [Abstract][Full Text] [Related]
9. Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers.
Izumi-Nakaseko H; Hagiwara-Nagasawa M; Naito AT; Goto A; Chiba K; Sekino Y; Kanda Y; Sugiyama A
J Pharmacol Sci; 2018 Aug; 137(4):372-378. PubMed ID: 30126708
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeys.
Regan CP; Morissette P; Regan HK; Travis JJ; Gerenser P; Wen J; Fitzgerald K; Gruver S; DeGeorge JJ; Sannajust FJ
Hepatology; 2016 Nov; 64(5):1430-1441. PubMed ID: 27474787
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationship and Voltage Dependence for the Drug-Drug Interaction between Amiodarone Analogs and MNI-1 at the L-type Cav Channel.
Wang J; Zeng H; Dong G; Waddell S; McCauley J; Lagrutta A
J Pharmacol Exp Ther; 2024 Apr; 389(2):229-242. PubMed ID: 38453526
[TBL] [Abstract][Full Text] [Related]
13. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
[TBL] [Abstract][Full Text] [Related]
14. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.
Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW
J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713
[TBL] [Abstract][Full Text] [Related]
15. Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.
Zeng H; Roman MI; Lis E; Lagrutta A; Sannajust F
J Pharmacol Toxicol Methods; 2016; 81():217-22. PubMed ID: 27222351
[TBL] [Abstract][Full Text] [Related]
16. High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds.
Lu HR; Whittaker R; Price JH; Vega R; Pfeiffer ER; Cerignoli F; Towart R; Gallacher DJ
Toxicol Sci; 2015 Dec; 148(2):503-16. PubMed ID: 26358003
[TBL] [Abstract][Full Text] [Related]
17. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
Goineau S; Castagné V
J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
[TBL] [Abstract][Full Text] [Related]
19. Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge.
Renet S; Chaumais MC; Antonini T; Zhao A; Thomas L; Savoure A; Samuel D; Duclos-Vallée JC; Algalarrondo V
Gastroenterology; 2015 Nov; 149(6):1378-1380.e1. PubMed ID: 26253303
[TBL] [Abstract][Full Text] [Related]
20. The assessment of electrophysiological activity in human-induced pluripotent stem cell-derived cardiomyocytes exposed to dimethyl sulfoxide and ethanol by manual patch clamp and multi-electrode array system.
Hyun SW; Kim BR; Hyun SA; Seo JW
J Pharmacol Toxicol Methods; 2017 Sep; 87():93-98. PubMed ID: 28377112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
